Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 22 citing Chan: Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment.... (0.07 sec) 

Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularization six-month results …


WM Chan, TYY Lai, DTL Liu, DSC Lam - Ophthalmology, 2007 - Elsevier
Cited by 39 - Related articles - All 24 versions

Intravitreous bevacizumab to treat subfoveal choroidal neovascularization in highly myopic …


JM Ruiz-Moreno, F Gomez-Ulla, JA Montero, S … - Eye, 2009 - phx1.medscape.com
New antiangiogenic drugs have been made available to treat subfoveal CNV
secondary to high myopia, although there have not been too many reports yet.
[11-20] The purpose of this pilot study is to evaluate the outcome of ...
Cited by 16 - Related articles - All 8 versions

Combination therapy for choroidal neovascularisation

- prsjournal.com
AJ Augustin, I Offermann - Drugs &# 38; Aging, 2007 - ingentaconnect.com
Choroidal neovascularisation (CNV) often leads to severe vision loss and is
Abstract becoming increasingly prevalent as the aging population grows.
Age-related macular degeneration (AMD) is the most common cause of CNV, but ...
Cited by 6 - Related articles - BL Direct - All 8 versions

Intravitreal ranibizumab (Lucentis®) for the treatment of myopic choroidal neovascularization


L Konstantinidis, I Mantel, JAC Pournaras, L … - Graefe's Archive for Clinical and Experimental …, 2009 - Springer
Abstract Background Macular choroidal neovascularization (CNV) is one of the
most vision-threatening complications of myopia, which can lead to severe vision
loss. The purpose of this study was to evaluate the safety and efficacy of ...
Cited by 6 - Related articles - All 2 versions

Photodynamic therapy with intravitreal application of triamcinolone acetonide in age-related …


A Frimpong-Boateng, A Bunse, F Rüfer, J … - Acta Ophthalmol, 2009 - interscience.wiley.com
It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ...
Cited by 4 - Related articles - All 2 versions

Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of …


JA Montero, JM Ruiz-Moreno - British Journal of Ophthalmology, 2007 - bjo.bmj.com
High myopia is a major cause of legal blindness in many developed countries,
affecting 2% of the general population. Myopic maculopathy, mainly in the form
of subfoveal choroidal neovascularisation (CNV), is the most common cause ...
Cited by 3 - Related articles - BL Direct - All 4 versions

Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularisation: 1-year results of …

- prsjournal.com
WM Chan, TYY Lai, DTL Liu, DSC Lam - British Journal of Ophthalmology, 2009 - bjo.bmj.com
Results: The mean spherical equivalent refractive error was −10.0 D. Sixteen
eyes had previous photodynamic therapy (PDT) and 13 eyes had no prior PDT. All
patients completed follow-up at 1 year. Following the initial three ...
Cited by 3 - Related articles - All 4 versions

Photodynamic therapy to treat choroidal neovascularisation in highly myopic patients: 4 …


JM Ruiz-Moreno, P Amat, JA Montero, F Lugo - British Medical Journal, 2008 - bjo.bmj.com
Methods: Prospective, consecutive, non-randomised interventional case series.
Thirty-nine eyes from 36 highly myopic patients treated by PDT were evaluated.
Best corrected visual acuity (BCVA) and fluorescein angiography were ...
Cited by 3 - Related articles - BL Direct - All 5 versions

Intravitreal bevacizumab to treat subfoveal choroidal neovascularisation in highly myopic …

- prsjournal.com
JM Ruiz-Moreno, JA Montero, F Gomez-Ulla, … - British Journal of Ophthalmology, 2009 - bjo.bmj.com
Results: The average age was 50 (SD 15, range 29–82) years. The mean LogMAR
BCVA at baseline was 0.55 (SD 0.25, range 0.2–1.0) and 0.38 (SD 0.32, range
0.0–1.2) at 1 year. Sixteen eyes were naïve for treatment and 13 eyes ...
Cited by 2 - Related articles - All 4 versions

脉络膜新生血管性疾病联合治疗的效果及其存在的问题


王雨生, 李夏 - 眼科, 2007 - 万方数据资源系统
随着对脉络膜新生血管(CNV)发生机制研究的深入,探索CNV相关疾病的最佳治疗手段已成为眼
科学领域研究的热点之一.研究显示,近年来针对CNV相关疾病开展的联合疗法的效果较单一 ...
Cited by 2 - Related articles - All 3 versions


Result Page: 

1

2

3

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google